Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

MEDIFAST INC Director's Dealing 2024

Jun 24, 2024

33899_dirs_2024-06-24_2bab2861-8b02-4290-bdfb-1f8a13df8776.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MEDIFAST INC (MED)
CIK: 0000910329
Period of Report: 2024-06-20

Reporting Person: BROWN JEFFREY J (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2024-06-20 Common Stock A 6596 Acquired 12379.647 Direct
2024-06-20 Common Stock A 5581 $22.66 Acquired 17960.647 Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 4232.967 Indirect

Footnotes

F1: 6,596 restricted stock units were granted under the Medifast, Inc. Director's Deferred Compensation Plan, as Amended and Restated (the "Plan"), in connection with the payment of the reporting person's annual director fees. Each unit represents the right to receive one share of the Issuer's common stock. These awards are granted from the Issuer's 2012 Share Incentive Plan and will vest in full on June 20, 2025.

F2: The reporting person elected, pursuant to the Plan, to receive shares of the Issuer's common stock in lieu of cash compensation for annual service as a non-employee director of the Issuer.

F3: This price per share of $22.66 is based on the 20-day moving average stock price of the Issuer's common stock as of June 18, 2024.

F4: These shares are directly owned by Jeffrey Brown Living Trust, for which the reporting person is the sole trustee and sole beneficiary.